Virus Filtration Market: Technological Advancements, Market Size, and Forecasts

The global virus filtration market size is expected to reach USD 9.5 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 10.1% from 2023 to 2030. Increasing demand for biological products such as vaccines, therapeutic proteins, blood and blood products, cellular and gene therapy, tissue, and stem cell products is a major factor driving the growth. Biopharmaceuticals are mainly derived from human, animal, and plants and therefore require a scrutinized virus filtration procedure to avoid virus contamination in the production. Therefore, the necessity of this procedure during the production of biologics is expected to boost the market growth.

Many leading biopharmaceuticals and biotechnology manufacturers are involved in RD to develop innovative biological products. For instance, in 2016, Pfizer Inc. invested USD 7,872.0 million in RD, which was around 8% more than the RD investment in 2015. This investment was mainly made to boost innovation and productivity in RD to accomplish a sustainable pipeline of vaccines and differentiated therapies with lucrative commercial opportunities. Virus filtration is an important step in biologics development, thus, increasing RD on biologics is expected to drive the product demand.

Virus Filtration Market Report Highlights

The consumables segment dominated the market with the largest revenue share in 2022 owing to the rising demand for these products for virus filtration.
Chromatography technology segment is expected to grow at the fastest CAGR during the forecast period, owing to product advancements and increasing RD and production of biologics.
Biologicals segment held the largest revenue share of 56.6% in 2022 and is expected to grow at the fastest CAGR of 10.9% over the forecast period due to rising prevalence of chronic diseases such as cancer, blood disorders, and diabetes
The biotechnology and biopharmaceutical companies segment is projected to expand at the fastest CAGR over the forecast period owing to increasing investment in RD and production of biologics
North America led the virus filtration market with the largest revenue share of 41.2% in 2022. Primarily due to the presence of several leading biotechnology companies and increased RD activities
Asia Pacific is estimated to grow at the fastest CAGR of 12.0% over the forecast period from 2023 to 2030 due to the growing number of road accidents and trauma cases.

Curious about the Virus Filtration Market? Get a FREE sample copy of the full report and gain valuable insights.

Virus Filtration Market Segmentation

Grand View Research has segmented the global virus filtration market based on product, technology, application, end-use, and region:

Virus Filtration Product Outlook (Revenue, USD Million, 2018 - 2030)

Consumables
- Kits and Reagents
- Others
Instruments
- Filtration Systems
- Chromatography Systems
Services

Virus Filtration Technology Outlook (Revenue, USD Million, 2018 - 2030)

Filtration
- Consumables
- Instruments
- Services
Chromatography
- Consumables
- Instruments
- Services

Virus Filtration Application Outlook (Revenue, USD Million, 2018 - 2030)

Biologicals
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Tissue and Tissue Products
- Stem Cell Products
Medical Devices
Water Purification
Air Purification

Virus Filtration End-use Outlook (Revenue, USD Million, 2018 - 2030)